Two Sigma Advisers’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $274K | Sell |
6,300
-61,400
| -91% | -$2.67M | ﹤0.01% | 2003 |
|
|
2025
Q1 | $2.53M | Sell |
67,700
-3,800
| -5% | -$142K | 0.01% | 1059 |
|
|
2024
Q4 | $3.24M | Buy |
71,500
+24,300
| +51% | +$1.1M | 0.01% | 892 |
|
|
2024
Q3 | $2.77M | Sell |
47,200
-5,200
| -10% | -$305K | 0.01% | 927 |
|
|
2024
Q2 | $2.06M | Buy |
52,400
+48,300
| +1,178% | +$1.9M | ﹤0.01% | 1177 |
|
|
2024
Q1 | $272K | Buy |
+4,100
| New | +$272K | ﹤0.01% | 2105 |
|